Neurolixis

Neurolixis is an early-stage biopharmaceutical company dedicated to the discovery and development of novel drugs for the treatment of human central nervous system (CNS) disorders, including Parkinson's disease, Rett syndrome, depression, and pain. Neurolixis was founded by experienced pharmaceutical industry professionals and has a world-class track record in CNS drug discovery, drug development, clinical trials, and company management.